A commercial model built to deliver blockbuster drugs to the market is no longer effective for delivering therapies for complex disease states to smaller, more targeted patient populations and specialty providers. The first in what will be an ongoing series of content on the future of commercial models, this paper outlines the path to a well-integrated model that considers key trends, specific influencers and their needs, and adoptable to address the specific needs of each disease state, and discusses the new ways that people will start to behave and operate within more integrated organizations, and how data will be generated and utilized to generate actionable insights and demonstrate value.
Click Here to read the white paper
Phone: +1 919 876 9300
Fax: +1 919 876 9360
Toll-Free: +1 866 462 7373
Howard Brock, Jackson Carroll